WJPR Citation New

  All Since 2011
 Citation  2903  2393
 h-index  27  24
 i10-index  68  60

Login

Best Paper Awards

World Journal of Pharmaceutical Research (WJPR) will give best paper award in every issue in the form of money along with certificate to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

MANAGEMENT OF CORONARY ARTERY DISEASE IN PATIENT WITH DIABETES

Jambukumar G.*, Leelavathi K., Arulkumar A., Sanjay S., Sivarajkumar S., Ponsivasankar M., Pavithra G. and Dr. A Suresh

Abstract

This review's objective is to go through the unique characteristics of Coronary Artery Disease; the impact of aggressive medicinal treatment and the results of Percutaneous and Surgical revascularization in people with Diabetes Mellitus. Coronary artery disease are significantly more prevalent in people with diabetes mellitus. According to various diagnostic techniques, the prevalence of CAD in adults with DM can reach up to 55%, compared to 2% to 4% in the general population.[1] A separate risk factor for increased mortality and morbidity is diabetes mellitus.[1–4] Men and women with DM have cardiovascular mortality rates that are more than twice as high as those of non-diabetics,[2,4] and these patients also have patients with a worse post-MI prognosis.[5–8] Additionally, it is known that diabetes mellitus increases the risk of a poor outcome from either percutaneous[9–17] or surgical[18–22] coronary revascularization. However, diabetics make up to 25% of patients who are referred for such procedures[9-13,15,22-27] Despite significant recent advancements in these procedures, there is still debate over the best therapeutic approach for diabetics.[14,17] In particular, the clinical, angiographic, metabolic, and biological characteristics of CAD in diabetics are covered in this review. In an effort to decide on the best therapeutic approach for this patient population, it also covers the effects of intensive medical management and the early and late outcomes following percutaneous transluminal coronary angioplasty (PTCA) and coronary artery bypass grafting (CABG).

Keywords: Coronary Heart disease, Diabetes, CABG, PTCA, Coronary revascularization.


[Full Text Article]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More